Korean and Japanese dramas are remaking each other’s biggest hits, and the trade runs in both directions. Japan has turned Extraordinary Attorney Woo into Extraordinary Attorney Minami, while Korea is adapting a long-running Japanese medical franchise for its own audience.
For US streaming fans, the Korean and Japanese drama remake trend is not an industry story happening far away. The same premise can arrive twice, from two TV cultures, with different pacing, humor, and ideas about work and authority, and global platforms are making both versions easier to find.
Why Korean and Japanese Dramas Keep Remaking Each Other
Remakes between the two countries are not a copy-paste business. They work as a form of cultural translation, according to Yun Suk-jin, a drama critic and professor at Chungnam National University.
“Problems in the medical and legal professions are universal, but the perspectives of the two countries on those problems are different,” Yun said. “The essence of a remake drama is to translate those differences well and give the story social meaning that fits the realities of each country.”
He also points to what each industry brings to the table. “The delicacy of Japanese dramas, which does not overlook even the smallest details of everyday life, can complement Korean dramas, while the dynamic storytelling and diverse structures of Korean dramas can work in the opposite direction in Japan,” he said.
Courtrooms and hospitals travel well because their stakes read clearly anywhere. The case-of-the-week structure helps too, since viewers can sample a story without committing to a full binge. That matters for shows built with global platforms in mind.
How the Remake Pipeline Moved From Melodrama to Genre
The earlier wave looked very different. In the 2000s, Korean and Japanese remakes leaned heavily on romance and melodrama, a period that produced titles like I’m Sorry, I Love You and Boys Over Flowers.
The 2004 KBS 2TV drama I’m Sorry, I Love You is a useful marker of that era. It ran for 16 episodes from Nov. 8 to Dec. 28, starred So Ji-sub and Im Soo-jung, and was exported to roughly 30 countries across Asia, the Pacific, Europe, and the Americas. Japan later remade it as Gomen, Aishiteru, and Turkey, China, and Thailand made their own versions, proof that remakes have always been a multi-country business rather than a simple two-way street.
The shift came in 2018, when Japanese versions of Signal and Good Doctor found back-to-back success. Attention moved toward well-made genre dramas, and that is the lane the current remakes are running in.
Japan’s Answer to Attorney Woo: Extraordinary Attorney Minami
Extraordinary Attorney Minami is the clearest example of the trend. Kansai TV and Fuji TV will premiere the series on Oct. 19, and it will be released worldwide through Netflix.
The premise matches the ENA original: a rookie lawyer on the autism spectrum learning to grow inside her profession. Extraordinary Attorney Woo became a global breakout after its 2022 run, spending 21 weeks in Netflix’s global Top 10.
Mana Ashida stars as Minami and said on the show’s official website that the offer surprised her because she had already been a fan of the Korean series. “I want to cherish the texture of the original, which delicately portrays not only the fun of a courtroom drama but also relationships and emotions,” she said.
The localization reaches even the show’s signature wordplay. Where Woo Young-woo introduced herself with words that read the same forward and backward, the Japanese remake rebuilds the joke around the palindrome name Minamida Minami. It is a small detail, but it shows what cultural translation looks like on screen, and it gives fans of the original a reason to watch a story they already know told with a different emotional texture.
Korea’s Answer: Doctor X and Lim Yoona’s Unnatural
Korea is sending stories in the other direction. SBS’s new Friday-Saturday drama Doctor X: Age of the White Mafia adapts TV Asahi’s Doctor-X: Surgeon Michiko Daimon, a franchise that ran for seven seasons starting in 2012.
SBS has billed the Korean take as a “refreshing medical noir.” Kim Ji-won plays Gye Su-jeong, a freelance surgeon who refuses tasks that can be done without a medical license, from hospital rounds to staff dinners, and focuses only on saving patients. The original’s “I never fail” catchphrase carries over as a connective thread between the two versions.
Medical dramas are a natural home for this kind of trade. High-stakes cases translate instantly, while hospital hierarchy and institutional corruption stay deeply local, which gives each version its own social edge.
A second remake is already in production. tvN’s Unnatural, a working title, continues the fictional universe of the 2018 TBS drama of the same name and follows a forensic pathologist at a fictional autopsy center tied to the National Forensic Service. Lim Yoona leads the cast, a genre challenge for an actor known mostly for romantic comedies. The target premiere is next year.
How to Watch and Compare the Remakes in the US
Netflix makes comparison viewing possible for the biggest of these titles. Extraordinary Attorney Minami is set for a worldwide release on the platform. US availability for Doctor X: Age of the White Mafia and tvN’s Unnatural has not been announced, so check listings closer to those premieres.
The most useful habit is to treat each pair as two separate shows rather than a winner and a loser. A remake can change a character’s job, a family structure, or the rhythm of a courtroom scene without touching the core premise. Things worth tracking:
- Casting, and what the lead choice signals about the version’s target audience.
- Setting, especially how courts, hospitals, and the people running them get framed.
- Case structure, whether episodes stay standalone or build toward a season-long arc.
- Tone, since Korean and Japanese television often handle the same emotional beat differently.
- Availability, meaning which platform carries which version in your region.
The next confirmed step is Oct. 19, when Extraordinary Attorney Minami arrives on Netflix worldwide. For viewers who finished the Korean original and wanted more, that is a rare offer: the same story, rebuilt by a different television industry.